affiliation not provided to SSRN
melanoma - access to medicines - disparities - cancer care - immunotherapy - targeted therapy
neonatal melanoma surgery treatment
Programmed cell death ligand 1, cemiplimab, D-dimer, cutaneous squamous cell carcinoma, disease control